May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Characterization of Sorsby’s Fundus Dystrophy-TIMP-3 Proteins in Human RPE Cells
Author Affiliations & Notes
  • K.P. Langton
    Academic Pathology, University of Sheffield, Sheffield, United Kingdom
  • N. McKie
    Geronotology & Rheumatology, University of Newcastle-Upon-Tyne, Newcastle-Upon-Tyne, United Kingdom
  • M.D. Barker
    Geronotology & Rheumatology, University of Newcastle-Upon-Tyne, Newcastle-Upon-Tyne, United Kingdom
  • Footnotes
    Commercial Relationships  K.P. Langton, None; N. McKie, None; M.D. Barker, None.
  • Footnotes
    Support  PPP foundation grant.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 5104. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K.P. Langton, N. McKie, M.D. Barker; Characterization of Sorsby’s Fundus Dystrophy-TIMP-3 Proteins in Human RPE Cells . Invest. Ophthalmol. Vis. Sci. 2003;44(13):5104.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Sorsby’s fundus dystrophy (SFD) is a fully penetrant, autosomal dominant macular degenerative disease caused by mutations in the tissue inhibitor of metalloproteinases-3 (TIMP-3) gene. While SFD is rare it closely resembles age-related macular degeneration (AMD) the most common form of blindness among the elderly in the developed world. Previously we have shown that SFD mutations promote TIMP-3 multimerization but do not affect its matrix metalloproteinase (MMP) inhibitory activity or extracellular matrix (ECM) binding. However, recently it has been suggested that SFD mutations do not cause TIMP-3 aggregation, but rather abolish its inhibitory action and actively promote proMMP-2 secretion/activation in human retinal pigment epithelial (RPE) cells. The aim of this study then, was to clarify the properties of SFD-TIMP-3 protein in human RPE cells. Methods: The human RPE cell-line, ARPE-19, was transfected with genes for TIMP-3, AlaTIMP-3 (which cannot inhibit MMPs) and the SFD-TIMP-3 mutants S181C, S156C and E139X. Matrix and conditioned media were analyzed for TIMP-3 content by gelatin reverse zymography and western blotting. Conditioned media was analyzed for pro-form and active MMP-2 levels by gelatin zymography. Results: ARPE-19 cells express TIMP-3 mostly as a 24 kDa non-glycosylated ECM bound protein. Transfection with TIMP-3 or AlaTIMP-3 genes augmented ECM bound TIMP-3 levels and lead to secretion of soluble TIMP-3. SFD-TIMP-3 mutants were not secreted into the culture media but were found in the ECM as a mixture of protein species, ranging from monomers through to large aggregates. These aggregates were removed by reduction. SFD-TIMP-3 and wild-type TIMP-3 protein were active MMP inhibitors, but AlaTIMP-3 was not. None of the proteins increased the levels of proMMP-2 secretion or activation from ARPE-19 cells. TIMP-3 and TIMP-3-S181C inhibited concanavalin A stimulated proMMP-2 activation but AlaTIMP-3, TIMP-3-S156C and -E139X did not. Conclusions: We have defined the common properties of a range of SFD proteins in RPE cells and shown that all are functional MMP inhibitors that are prone to aberrant intermolecular interactions. However, they do not promote MMP secretion or activation and not all are impaired with regard to their ability to prevent MMP activation. Thus dysregulation of MMP activity is not likely to be a common factor in SFD.

Keywords: retinal degenerations: hereditary • extracellular matrix • retina 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.